4.7 Review

Inclusion Body Myositis and Neoplasia: A Narrative Review

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

The decreased serum activity of cytosolic 5′-nucleutiddse IA as a potential maker of breast cancer-associated muscle infiarnmdtion

Agata Jedrzejewska et al.

Summary: cN-IA activity is decreased in breast cancer patients, potentially due to the presence of specific autoantibodies, suggesting its potential as a biomarker for BC-associated polymyositis.

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2022)

Article Medicine, General & Internal

Identification of Hub Genes and Biological Pathways in Inclusion Body Myositis Using Bioinformatics Analysis

Yue Wu et al.

Summary: This study identified hub genes and signaling pathways related to inclusion body myositis (IBM) through the analysis of gene expression data. Enrichment analyses revealed the key roles of the chemokine signaling pathway, cellular response to interferon-gamma, and P53 pathway in IBM. Immune infiltration analyses showed altered levels of immune cells in IBM patients. Additionally, potential drugs for IBM treatment were predicted through database analysis.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2022)

Article Rheumatology

Defining anti-synthetase syndrome: a systematic literature review

Giovanni Zanframundo et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2022)

Review Pharmacology & Pharmacy

Calpain as a therapeutic target in cancer

Ivan Shapovalov et al.

Summary: Pre-clinical and clinical studies have shown that inhibition of calpain-1 and calpain-2 has the potential to attenuate carcinogenesis and block metastasis of aggressive tumors. However, the wide range of substrates and cleavage products, as well as inconsistencies in model systems, highlight the need for a better understanding of physiological substrates and how calpain cleavage affects their functions in cellular processes. The development of isoform specific calpain inhibitors remains an important goal with therapeutic potential in cancer and other diseases.

EXPERT OPINION ON THERAPEUTIC TARGETS (2022)

Article Clinical Neurology

Comprehensive transcriptomic analysis shows disturbed calcium homeostasis and deregulation of T lymphocyte apoptosis in inclusion body myositis

Mridul Johari et al.

Summary: The study investigates the molecular mechanisms in inclusion body myositis (IBM) through gene expression and splicing analysis. It reveals dysregulation of genes involved in calcium homeostasis and their impact on T-cell functioning in IBM muscles, suggesting that loss of apoptotic control of cytotoxic T cells may contribute to the abnormal cytolytic activity in IBM.

JOURNAL OF NEUROLOGY (2022)

Article Rheumatology

Survival and associated comorbidities in inclusion body myositis

Elie Naddaf et al.

Summary: This study evaluated the survival and associated comorbidities in inclusion body myositis (IBM) patients. The results showed that IBM was associated with lower survival, and higher frequency of peripheral neuropathy, Sjogren's syndrome, and hematologic malignancies.

RHEUMATOLOGY (2022)

Article Oncology

A prognostic immune predictor, HLA-DRA, plays diverse roles in nonmuscle invasive and muscle invasive bladder cancer

Xuan-Mei Piao et al.

Summary: The HLA-DRA expression level in bladder cancer patients is closely related to disease progression and prognosis, providing important implications for patient classification and immunotherapy.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)

Article Rheumatology

A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies

Alexander G. S. Oldroyd et al.

Summary: Clinical factors associated with increased and decreased cancer risk in IIM patients were identified through systematic literature review and meta-analysis. Factors such as DM subtype, older age, male sex, dysphagia, cutaneous ulceration, and anti-transcriptional intermediary factor were found to increase cancer risk, while factors like PM subtype, Raynaud's phenomenon, interstitial lung disease, high serum creatine kinase or lactate dehydrogenase levels, and certain autoantibody positivity were associated with reduced cancer risk. Additionally, limited evidence suggested that CT scanning could be effective for cancer screening in IIM patients, highlighting the need for further research and consensus guidelines.

RHEUMATOLOGY (2021)

Article Medicine, General & Internal

Idiopathic inflammatory myopathies

Ingrid E. Lundberg et al.

Summary: Idiopathic inflammatory myopathies, also known as myositis, are a group of autoimmune disorders with heterogeneous clinical manifestations and organ involvement. Different subtypes have varying prognoses, treatment responses, and organ manifestations, highlighting the importance of understanding the underlying pathophysiological mechanisms.

NATURE REVIEWS DISEASE PRIMERS (2021)

Review Oncology

The Regulatory Role of RNA Metabolism Regulator TDP-43 in Human Cancer

Xueyou Ma et al.

Summary: TDP-43 plays a crucial role in human cancers by regulating RNA metabolism events that impact the development of cancer. Research has systematically summarized the function and mechanisms of TDP-43 in different cancers, providing important foundations for future tumor treatment and diagnosis.

FRONTIERS IN ONCOLOGY (2021)

Review Immunology

Roles and Regulation of Growth differentiation factor-15 in the Immune and tumor microenvironment

Rathna Silviya Lodi et al.

Summary: Growth differentiation factor-15 (GDF-15) is a member of the TGF-beta superfamily and is highly expressed in tumor and tumor microenvironment (TME)-related cells, affecting stromal cells and immune cells in the TME, as well as regulating immune checkpoints. It exhibits both protumorigenic and antitumorigenic effects, making it a potential diagnostic biomarker and therapeutic target in cancer.

HUMAN IMMUNOLOGY (2021)

Review Oncology

Large Granular Lymphocytic Leukemia: From Immunopathogenesis to Treatment of Refractory Disease

Misam Zawit et al.

Summary: Large Granular Lymphocytic Leukemia (LGLL) is a rare clonal disorder of cytotoxic T-cells that may require treatment due to a variety of clinical presentations. The disease primarily involves immunosuppressive agents for treatment, but refractory cases may require exploration of alternative targeted treatment modalities. Research into immune-genomic profiles of LGLL aims to identify potential novel therapeutic agents for refractory disease.

CANCERS (2021)

Article Clinical Neurology

The role of interferons type I, II and III in myositis: A review

Lois Bolko et al.

Summary: The classification of idiopathic inflammatory myopathies is based on clinical, serological, and histological criteria. The identification of myositis-specific antibodies has helped to define more homogeneous groups of myositis into four dominant subsets, each with distinct pathophysiological mechanisms. Additionally, interferon pathways have been identified as key players in the pathophysiology of myositis, with different types of interferons playing specific roles in each subset.

BRAIN PATHOLOGY (2021)

Article Clinical Neurology

Chaperones in sporadic inclusion body myositis-Validation of proteomic data

Anne-Katrin Guettsches et al.

MUSCLE & NERVE (2020)

Article Immunology

Sestrins induce natural killer function in senescent-like CD8+ T cells

Branca Pereira et al.

NATURE IMMUNOLOGY (2020)

Review Biochemistry & Molecular Biology

p62: Friend or Foe? Evidences forOncoJanusandNeuroJanusRoles

Sonia Emanuele et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Oncology

The CCL5/CCR5 Axis in Cancer Progression

Donatella Aldinucci et al.

CANCERS (2020)

Review Biochemistry & Molecular Biology

Targeting STAT3 in Cancer Immunotherapy

Sailan Zou et al.

MOLECULAR CANCER (2020)

Review Oncology

Roles of IFN-γ in tumor progression and regression: a review

Dragica Jorgovanovic et al.

BIOMARKER RESEARCH (2020)

Editorial Material Pharmacology & Pharmacy

Evidence for a Cross-Talk Between Cytosolic 5′-Nucleotidases and AMP-Activated Protein Kinase

Marcella Camici et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Cell Biology

The role of senescent T cells in immunopathology

Luciana P. Covre et al.

AGING CELL (2020)

Article Rheumatology

MicroRNA and mRNA profiling in the idiopathic inflammatory myopathies

Joanna E. Parkes et al.

BMC RHEUMATOLOGY (2020)

Article Medicine, Research & Experimental

Association between TDP-43 and mitochondria in inclusion body myositis

Mikayla L. Huntley et al.

LABORATORY INVESTIGATION (2019)

Review Rheumatology

Inclusion body myositis: clinical features and pathogenesis

Steven A. Greenberg

NATURE REVIEWS RHEUMATOLOGY (2019)

Article Immunology

Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis

Adam Amlani et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Clinical Neurology

PD 1 pathway in immune-mediated myopathies Pathogenesis of dysfunctional T cells revisited

Samuel Knauss et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)

Article Biochemistry & Molecular Biology

GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance

Harding H. Luan et al.

Article Clinical Neurology

Identification of distinctive interferon gene signatures in different types of myositis

Iago Pinal-Fernandez et al.

NEUROLOGY (2019)

Review Clinical Neurology

Malignancy and myositis, from molecular mimicry to tumor infiltrating lymphocytes

Albert Selva-O'Callaghan et al.

NEUROMUSCULAR DISORDERS (2019)

Article Multidisciplinary Sciences

Amyloid β oligomers inhibit growth of human cancer cells

Bozena Pavliukeviciene et al.

PLOS ONE (2019)

Review Biochemistry & Molecular Biology

p62/SQSTM1: 'Jack of all trades' in health and cancer

Pablo Sanchez-Martin et al.

FEBS JOURNAL (2019)

Review Oncology

Tumor infiltrating lymphocytes: The regulator of melanoma evolution

Mihaela Antohe et al.

ONCOLOGY LETTERS (2019)

Review Biochemistry & Molecular Biology

Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras

Boel De Paepe

BIOMOLECULES (2019)

Review Immunology

Mechanisms underlying T cell ageing

Jorg J. Goronzy et al.

NATURE REVIEWS IMMUNOLOGY (2019)

Article Oncology

Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL)

Srinivasa R. Sanikommu et al.

LEUKEMIA & LYMPHOMA (2018)

Article Rheumatology

New Developments in the Genetics of Inclusion Body Myositis

Kyla A. Britson et al.

CURRENT RHEUMATOLOGY REPORTS (2018)

Review Biochemistry & Molecular Biology

STAT3 in Skeletal Muscle Function and Disorders

Eleonora Guadagnin et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Immunology

IFN gamma-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin

Ryan S. Lane et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Review Cell Biology

Mitochondrial metabolism and cancer

Paolo Ettore Porporato et al.

CELL RESEARCH (2018)

Article Dermatology

Risk of Malignancy in Dermatomyositis and Polymyositis: A Systematic Review and Meta-Analysis

Judy K. Qiang et al.

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2017)

Article Oncology

Characterization and risk estimate of cancer in patients with primary Sjogren syndrome

Pilar Brito-Zeron et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)

Review Clinical Neurology

Immune and myodegenerative pathomechanisms in inclusion body myositis

Christian W. Keller et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2017)

Article Medicine, General & Internal

Necrotizing Autoimmune Myopathy: A Rare Variant of Idiopathic Inflammatory Myopathies

Noman Ahmed Jang Khan et al.

JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS (2017)

Article Clinical Neurology

Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis

Anne-Katrin Guettsches et al.

ANNALS OF NEUROLOGY (2017)

Review Medicine, General & Internal

Diagnostic criteria for inclusion body myositis

D. Hilton-Jones et al.

JOURNAL OF INTERNAL MEDICINE (2016)

Review Rheumatology

Novel serology testing for sporadic inclusion body myositis: disease-specificity and diagnostic utility

Megan K. Herbert et al.

CURRENT OPINION IN RHEUMATOLOGY (2015)

Article Biochemistry & Molecular Biology

Inhibition of Stat3 Activation Suppresses Caspase-3 and the Ubiquitin-Proteasome System, Leading to Preservation of Muscle Mass in Cancer Cachexia

Kleiton Augusto Santos Silva et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Article Clinical Neurology

MAGNETIC RESONANCE IMAGING PATTERN RECOGNITION IN SPORADIC INCLUSION-BODY MYOSITIS

Giorgio Tasca et al.

MUSCLE & NERVE (2015)

Article Clinical Neurology

Mitochondrial and inflammatory changes in sporadic inclusion body myositis

K. A. Rygiel et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2015)

Review Rheumatology

Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort

Gerd Cecilie Dobloug et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)

Review Oncology

Ki67 is a promising molecular target in the diagnosis of cancer

Lian Tao Li et al.

MOLECULAR MEDICINE REPORTS (2015)

Article Biochemistry & Molecular Biology

Aberrant cell cycle reentry in human and experimental inclusion body myositis and polymyositis

Bumsup Kwon et al.

HUMAN MOLECULAR GENETICS (2014)

Article Clinical Neurology

Autoantibodies to cytosolic 5′-nucleotidase 1A in inclusion body myositis

Helma Pluk et al.

ANNALS OF NEUROLOGY (2013)

Review Physiology

Aging, Cellular Senescence, and Cancer

Judith Campisi

ANNUAL REVIEW OF PHYSIOLOGY, VOL 75 (2013)

Review Biology

LKB1 and AMPK and the cancer-metabolism link - ten years after

D. Grahame Hardie et al.

BMC BIOLOGY (2013)

Article Immunology

Targeting IL-15 in large granular lymphocyte leukemia

Steven N. Steinway et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2013)

Review Biochemistry & Molecular Biology

Protein breakdown in muscle wasting: Role of autophagy-lysosome and ubiquitin-proteasome

Marco Sandri

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)

Article Biochemistry & Molecular Biology

STAT1 Gene Expression Is Enhanced by Nuclear EGFR and HER2 via Cooperation With STAT3

Woody Han et al.

MOLECULAR CARCINOGENESIS (2013)

Article Endocrinology & Metabolism

JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia

Andrea Bonetto et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)

Article Neurosciences

Foxo/Atrogin induction in human and experimental myositis

Han-Kyu Lee et al.

NEUROBIOLOGY OF DISEASE (2012)

Article Medicine, General & Internal

Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia

Hanna L. M. Koskela et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Clinical Neurology

Long-term observational study of sporadic inclusion body myositis

Olivier Benveniste et al.

Article Multidisciplinary Sciences

Autoantibodies against a 43 KDa Muscle Protein in Inclusion Body Myositis

Mohammad Salajegheh et al.

PLOS ONE (2011)

Article Biochemistry & Molecular Biology

Microtubule-Associated Protein Tau in Human Prostate Cancer Cells: Isoforms, Phosphorylation, and Interactions

Skye Souter et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2009)

Article Multidisciplinary Sciences

Distinctive patterns of microRNA expression in primary muscular disorders

Iris Eisenberg et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Rheumatology

Familial inflammatory inclusion body myositis

B Ranque-Francois et al.

ANNALS OF THE RHEUMATIC DISEASES (2005)

Article Medicine, General & Internal

Incidence of malignant disease in biopsy-proven inflammatory myopathy - A population-based cohort study

R Buchbinder et al.

ANNALS OF INTERNAL MEDICINE (2001)